1. A method of manufacturing an activated leukocyte composition, comprising: a. incubating a person’s white blood cells for a period of time so that the white blood cells transition from a resting state to a functionally active state b. leukocyte exposure to hypoosmotic shock c. adding to the leukocyte stage b, a physiologically acceptable saline solution in an amount sufficient to restore isotonicity； d. it is possible to contact a separate sample of human plasma with a coagulant to obtain serum, where white blood cells and plasma can be obtained from the same donor or from different donors； as well. possibly mixing stage white blood cells with serum of stage d.2. The method according to claim 1, characterized in that the incubation occurs at a temperature of from about 12 ° C to about 28 ° C for from about 90 minutes to about 2, 3, 4, 5, 6, 7, 8, or 12-20 part 3. The method according to claim 1, characterized in that the incubation occurs at a temperature of up to about 37 ° C for about 5-24 hours. The method according to claim 1, characterized in that the leukocytes are obtained from a donor having a blood group of 0, Rhesus negative, and plasma is obtained from a donor having a blood group of AB, Rhesus positive. A method according to any one of claims 1 to 4, characterized in that the hypoosmotic shock comprises contacting white blood cells with water, where the physiologically acceptable saline solution is a sodium chloride solution. The method according to claims 1 to 4, characterized in that it further includes the incubation of leukocytes in serum at a temperature of approximately 37 ° C. An activated leukocyte composition comprising: a) from about 40% to about 90% of granulocytes； b)1. Способ изготовления активированной лейкоцитарной композиции, включающий:a. инкубацию лейкоцитов человека в течение некоторого периода времени, чтобы лейкоциты перешли от состояния покоя к функционально активному состоянию；b. подвергание лейкоцитов гипоосмотическому шоку；c. д
